跳至主要内容
临床试验/ISRCTN50390099
ISRCTN50390099已完成不适用

The effect of rebamipide for healthy subjects with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)-induced small-intestinal injury: a prospective, randomised, double-blinded, placebo-controlled study

Individual Sponsor (Japan)0 个研究点目标入组 72 人开始时间: 2007年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Male sex
  • 2. Aged at least 20 years
  • 3. Body Mass Index (BMI) 18.5 - 25 kg/m^2
  • 4. Lack of history of GastroIntestinal (GI) disorder
  • 5. Japanese population
  • 6. Healthy on examination by a physician
  • 7. Subject able to comprehend and give informed consent for participation in this study
  • 8. Signed informed consent form

排除标准

  • 1. Active gastrointestinal disease
  • 2. Use of ulcerogenic medications within two weeks before starting the study
  • 3. Prior gastric or intestinal surgery
  • 4. Pregnancy
  • 5. Physician objection
  • 6. Concurrent participation in any other clinical trial

研究者

发起方
Individual Sponsor (Japan)

相似试验

The effect of rebamipide for healthy subjects with... | 临床试验